From: Evidence of d-phenylglycine as delivering tool for improving l-dopa absorption
 | d-phenylglycine-l-dopa | l-dopa | ||
---|---|---|---|---|
i.v. | Oral | i.v. | Oral | |
AUC (mg·min/ml) | 62.53 ± 19.68 | 28.85 ± 8.52 | 459.81 ± 195.14 | 27.37 ± 4.60 |
t1/2(min) | 254.10 ± 73.05 | 142.50 ± 23.71 | 101.52 ± 27.74 | 184.80 ± 46.20 |
Clp (l/kg/min) | 0.18 ± 0.06 | 0.29 ± 0.10 | 0.02 ± 0.02 | 0.01 ± 0.00 |
Vdss (l/kg) | 11.01 ± 5.08 | 35.7 ± 17.1 | 1.22 ± 0.89 | 1.22 ± 0.36 |
tmax(min) | – | 38.30 ± 17.72 | – | 25.02 ± 16.10 |
Fraction of absorption (%) | – | 27.58 ± 4.56 | – | 0.87 ± 0.24 |